In the setting of fixed-dose combinations with metformin, the cumulative effect may amplify HbA1c reduction due to complementary mechanisms, namely reduced hepatic glucose production and SGLT2-induced glucosuria as previously stated. This evidence concerns the gene SLC5A2 and Glycosuria.